Based on the aggregated intelligence of 170,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, robotic radiosurgery specialist Accuray (Nasdaq: ARAY) has earned a respected four-star ranking.

With that in mind, let's take a closer look at Accuray's business and see what CAPS investors are saying about the stock right now.

Accuray facts

Headquarters (Founded)

Sunnyvale, Calif. (1990)

Market Cap

$682.3 million

Industry

Health-care equipment

Trailing-12-Month Revenue

$206.04 million

Management

CEO Dr. Euan Thomson (since 2002)

CFO Derek Bertocci (since 2009)

Return on Equity (Average, Past 3 Years)

0.7%

Cash/Debt

$151.94 million / $0

Competitors

TomoTherapy (Nasdaq: TOMO)

Varian Medical Systems (NYSE: VAR)

Sources: Capital IQ (a division of Standard & Poor's) and Motley Fool CAPS.

On CAPS, 95% of the 559 members who have rated Accuray believe the stock will outperform the S&P 500 going forward. These bulls include guseter and ravens9111.

Late last year, guseter tapped Accuray as a sharp selection:

Another unique-in-its-field company, also developing a constantly growing list of procedures for which Acuray's equipment will be the radiological treatment of choice, especially because its equipment automatically compensates for movements that take place during treatment of the targeted cancer site.

Over the next five years, Accuray is expected to grow its bottom line at a brisk pace of 29% annually. That's faster than listed rivals TomoTherapy (25%) and Varian Medical (15.6%), as well much larger surgical-robot play Intuitive Surgical (Nasdaq: ISRG) (23%).

CAPS member ravens9111 elaborates on Accuray's CyberKnife system:

… I think this one goes much higher as the CK is being developed for other uses such as brain, neck, liver, lung, breast, and prostate cancer. Radiosurgery will become the preferred method of treatment over invasive surgery. CK is well positioned to take advantage of this trend. Although Varian has a competing product, the CK is the superior choice. This company is in high growth mode. Watch out for this one. New management will make this one a winner.

What do you think about Accuray, or any other stock for that matter? If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future, and on Motley Fool CAPS, thousands of investors are working every day to find them. CAPS is 100% free, so get started!

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Intuitive Surgical is a Motley Fool Rule Breakers pick. Try any of our Foolish newsletter services free for 30 days.

We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool's disclosure policy always gets a perfect score.